- Subcontracted R&D, which can affect eligibility for R&D tax credits and the scheme which applies.
- Funded R&D activities, which affect the schemes of R&D tax incentives which apply.
- R&D Expenditure Credits, which are reported differently in the financial statements and can affect the timing as well as the amount of tax payable.
- Corporate groups, where arrangements between companies can affect the R&D tax credits and also the Patent Box relief.
- ‘Capitalisation’ of development costs, where a company’s decision to report R&D expenditure as an asset, rather than as a cost in the year creates much greater complexity in the overall tax treatment of the costs and eligibility for R&D tax incentives.
- Interaction between R&D tax incentives and Patent Box, which will require companies to ‘track and trace’ their qualifying R&D expenditure in an appropriate way.
Research, industry, and AGI
A transfer of knowledge to industry is a good thing: One purpose of a university is to benefit society by disseminating knowledge, and one way this can be done is by commercialising research. Universities and research institutions are a dynamo for entrepreneurship, and for innovation in large companies. READ MORE
For success in product development – start at square zero
When it comes to the commercial success of a technology-led product, there are a number of factors that come into play along the development journey. Have the regulatory requirements been met? Can the design be produced at a viable cost? Is it possible to ensure the quality of the manufacturing process? The list goes on. READ MORE
The not-so-small matter of scale: Making it big in microfluidics
Microfluidics is a key technology enabling the development of rapid in-vitro diagnostics (IVD). With applications including COVID-19 testing, cardiac arrest assessment and STD screening, decentralised rapid diagnostics are shaping up to be a major part of the future of healthcare and wellness monitoring. READ MORE